Posted in | News | Semiconductors

Atomica Attracts Capital from Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital

Atomica Corp, a leader of micro-electro-mechanical systems (MEMS), today announced a $30 million Series C financing. The round was funded by Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital. The new financing allows Atomica to expand its foundry capabilities, advance MEMS technologies, and support domestic production of biochips, sensors, and photonic circuits.

Image Credit: Atomica Corp

Atomica is a pioneer in manufacturing Micro Electro-Mechanical Systems (MEMS). MEMS technologies leverage the precision and scale of semiconductor wafer manufacturing to make micro and nano-scale structures on silicon, glass, and other substrates to significantly improve the performance and economics of chips used for sensing and mechanical functions. Atomica is the leading U.S. MEMS foundry, partnering with innovative system-vendors and fabless device firms globally to bring new technologies to life.

"Atomica has differentiated itself as a world-class MEMS company addressing design, development, and fabrication solutions across the full spectrum of MEMS use cases that aim to solve today’s most pressing problems.” - Robert Lautz, Co-Founder of St. Cloud Capital

“As highlighted by the recently passed CHIPS Act, the U.S. must re-establish leadership in semiconductor manufacturing including MEMS semiconductor chips for emerging applications such as genomics, cell therapies, molecular diagnostics, IoT sensing, and autonomous vehicles,” said Atomica CEO, Eric Sigler. “We are pleased to garner the support of new capital partners St. Cloud and Novo Tellus, as well as the continued commitment of Cerium. These investments aid our efforts to grow and protect domestic U.S. manufacturing of MEMS and related semiconductor technologies.”

“As sector investors, we invest behind long-term secular trends and innovative management teams who are passionate about their mission. We see that at Atomica and we are excited to support management in their growth journey,” said Wai San Loke, Co-Founder and Managing Partner of Novo Tellus Capital Partners.

Robert Lautz, Co-Founder of St. Cloud Capital adds, “We are extremely pleased to facilitate Atomica’s next chapter of growth in partnership with the management team, Cerium Technology Ventures, and Novo Tellus Capital Partners. Atomica has differentiated itself as a world-class MEMS company addressing design, development, and fabrication solutions across the full spectrum of MEMS use cases that aim to solve today’s most pressing problems.”

“Atomica is a very special company, uniquely positioned to capitalize on the enormous potential of MEMS technology. Cerium is delighted to increase our investment and participate in the exciting future of the company,” notes Cerium Managing Director, Eldon Klaassen.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Atomica Corp.. (2024, September 04). Atomica Attracts Capital from Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital. AZoOptics. Retrieved on September 16, 2024 from https://www.azooptics.com/News.aspx?newsID=29932.

  • MLA

    Atomica Corp.. "Atomica Attracts Capital from Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital". AZoOptics. 16 September 2024. <https://www.azooptics.com/News.aspx?newsID=29932>.

  • Chicago

    Atomica Corp.. "Atomica Attracts Capital from Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital". AZoOptics. https://www.azooptics.com/News.aspx?newsID=29932. (accessed September 16, 2024).

  • Harvard

    Atomica Corp.. 2024. Atomica Attracts Capital from Cerium Technology Ventures, Novo Tellus Capital Partners, and St. Cloud Capital. AZoOptics, viewed 16 September 2024, https://www.azooptics.com/News.aspx?newsID=29932.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.